HER2 in Breast Cancer
2014 · Advances in Anatomic Pathology · 312 citations
https://doi.org/10.1097/pap.0000000000000015
U
Uma Krishnamurti
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
108
Papers
2.0K
Citations
25
h-index
41
i10-index
Uma Krishnamurti is an academic researcher from Yale New Haven Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cervical Cancer and HPV Research & HER2/EGFR in Cancer Research. The author has an h-index of 25, co-authored 92 publications.
ORCID: 0000-0001-5848-8748Papers by this author
worksPoor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma
2009 · Modern Pathology · 57 citations
https://doi.org/10.1038/modpathol.2009.61
Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers
2020 · Scientific Reports · 55 citations
https://doi.org/10.1038/s41598-020-59514-1
CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition
2016 · British Journal of Cancer · 50 citations
https://doi.org/10.1038/bjc.2016.113
New Developments in Breast Cancer and Their Impact on Daily Practice in Pathology
2017 · Archives of Pathology & Laboratory Medicine · 46 citations
https://doi.org/10.5858/arpa.2016-0288-sa
Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer
2020 · Breast Cancer Research · 34 citations
https://doi.org/10.1186/s13058-020-01308-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat